Le marché de la lyophilisation

Le marché mondial de la lyophilisation devrait atteindre 3,26 milliards de dollars américains en 2014, en raison notamment du fort développement de nouveaux médicaments.
The global market for lyophilisation is projected to be worth USD 3.26 billion in 2015, spurred by the strong growth of new drugs and efforts to increase clinical approval. Lyophilisation (also known as freeze-drying) is an established method in the formulation of biological products, and an invaluable tool for prolonging shelf life and stability for biological drugs and vaccines.

As under met needs in drug transport and long term storage continues, robust lyophilisation methods outlined in PAT and QbD principles as well as alternative technologies will continue to experience strong demand.

There’s a growing demand for lyophilised pharmaceutical products in the US that are contributing towards an increase in the use of lyophilisation equipment and the need for lyophilised biopharmaceuticals and other formulations in the pharmaceutical industry. This is contributing to the projected rise in investment, currently dominated by North America, which is expected to reach USD 4.80 billion in 2020. This rate of growth is a result of new biologics and biosimilars, enhancing the need for lyophilisation equipment and services.

Source: SMi-online